Nasdaq Welcomes Baltic RE Group to Baltic Market

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 13, 2016 at 4:15 AM

Tallinn/Riga/Vilnius, Nasdaq Baltic Market, December 13, 2016 – Nasdaq (Nasdaq: NDAQ) announces that bonds of Baltic RE Group, AS (short name: BRE), Latvian real estate company, will be listed on the Baltic Bond List by Nasdaq Riga as of December 16, 2016. The size of the bond issue is EUR 4 million. The nominal value of one bond is EUR 1 000. The annual interest rate is fixed: 6.15% with coupon payment twice a year. Maturity date of the bond issue is December 12, 2020. The issuer is entitled to premature redemption. ABLV Bank was the arranger of the bond issue. The bond issue was performed to raise additional capital to finance company’s development plans. “It is a pleasure to welcome Baltic RE Group to Nasdaq Riga. This is the fifth newcomer joining Baltic bond market this year,” says Daiga Auziņa-Melalksne, Head of Exchange Services at Nasdaq Baltic and Head of Nasdaq Riga. “For fast growing companies seeking to diversify funding sources listing of bonds is a great first step towards building reputation in capital markets.” “We are proud to be the first real estate company in Latvia whose bonds are included in the regulated market. In such a light successful placement of the bonds, which were quickly sold out, is for us the confirmation of the quality of the work done so far, with the right balance between value growth and financial prudence,” says Giovanni Dalla Zonca, the Chairman of the Board of Baltic RE Group. “We firmly believe in openness to the market as a healthy and transparent tool for growth. This listing is an important step which lays the foundation for our company’s further growth in the Baltic region, whose potential we are convinced of.” Baltic RE Group is an experienced real estate investor specialized in the set up and management of value-added and core property portfolios in the Baltics. The main lines of Baltic RE Group business are investing in prime retail locations and landmark commercial mixed-use properties, to enhance its leadership position in its segment and to continue to be the benchmark for investments in high street properties in Latvia and, soon, in the other Baltic countries. For more information, please visit: balticregroup.com . About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,700 listed companies with a market value of $9.3 trillion and over 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com . Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB, Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic Market represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius. Read more: nasdaqbaltic.com . Cautionary Note Regarding Forward-Looking Statements The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements. Media Relations Contact: Audronė Ranonytė +370 5 253 1475 audrone.ranonyte@nasdaq.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

AI and Storytelling Make Waves in Science Education

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Jackson Wang's Fantasy IP Hits Hong Kong Stage

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Quay Sunglasses: Luxury Looks, Affordable Prices

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

PACS Group Faces Legal Scrutiny: What to Watch

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...